Be a part of Medical Revolution break-through with Innovation Driven Medical Technology using Cannabis for Treatment of Cancer, Multiple Sclerosis, Epilepsy, HIV/AIDS, Post-Traumatic Stress Disorder and many more chronic diseases.
The Company through its Medical Research Institute has successfully modified & re-engineered the Cannabis plant. The genetically modified plant enhances properties of the Cannabis to be used for medical purpose.
β’ Project Conceptualization Started<br />
<br />
β’ Corporation with various blockchain specialist, advisors to form strategic alliance<br />
<br />
β’ Form Strategic Alliance with other Medical Cannabis Research and Cultivation companies<br />
2nd Half, 2018
β’ ICO - Pre-Sale & Institutional Sale<br />
<br />
β’ Pre- ICO 10% & ICO 50% of the coins will be distributed to expand EIMCR<br />
<br />
β’ Form strategic alliance with R&D departments in Universities in the area<br />
<br />
β’ Finalise discussions with Governmental figures<br />
1st Half, 2019
β’ Strategic Alliance with companies to produce MCan Products<br />
<br />
β’ Establishment of pharmaceutical manufacturing facilities<br />
<br />
β’ Production of MCan cultivation Begins <br />
2nd Half, 2019
β’ Adding more and the very best Consultants, Doctors and Scientists.<br />
<br />
β’ Medical Cannabis harvest<br />
<br />
β’ All Production of MCan Products Begins<br />
2020
β’ Aggressive expansion to 13 new countries<br />
<br />
β’ Expansion to new verticals, concrete plans set and teams ready to expand to 13 countries in 2 years.<br />
2021
β’ IPO (Initial Public Offering in major Global Exchanges)<br />
<br />
β’ NASDAQ, London Stock Exchange (LSE).<br />
<br />
β’ Further expansion & Global dominance<br />
<br />
β’ Aggressive marketing in current markets to 8 more new countries in 2 years.<br />
<br />
β’ Expansion of Manufacturing Facilities in few countries.<br />
<br />
β’ Blockchain era continues.<br />
.webp)
.png)
